Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
927.15
3.50 (0.38%) Natco Pharma - Quaterly Results
Date: 30-05-2022
The turnover is pegged at Rs. 5141.00 millions for the March 2022 quarter. The mentioned figure indicates a rise of about 65.04% as against Rs. 3115.00 millions during the year-ago period.The Net Loss for the quarter ended March 2022 is Rs. -613.00 millions as compared to Net Profit of Rs. 572.00 millions of corresponding quarter ended March 2021Operating profit Margin for the quarter ended March 2022 slipped to -273.00% as compared to 1055.00% of corresponding quarter ended March 2021
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202203 | 202103 | % Var | 202203 | 202103 | % Var | 202203 | 202103 | % Var | |
| Sales | 5141.00 | 3115.00 | 65.04 | 17678.00 | 16535.00 | 6.91 | 17678.00 | 16535.00 | 6.91 |
| Other Income | 104.00 | 291.00 | -64.26 | 946.00 | 1011.00 | -6.43 | 946.00 | 1011.00 | -6.43 |
| PBIDT | -273.00 | 1055.00 | -125.88 | 3076.00 | 5187.00 | -40.70 | 3076.00 | 5187.00 | -40.70 |
| Interest | 42.00 | 23.00 | 82.61 | 133.00 | 113.00 | 17.70 | 133.00 | 113.00 | 17.70 |
| PBDT | -315.00 | 1032.00 | -130.52 | 2943.00 | 5074.00 | -42.00 | 2943.00 | 5074.00 | -42.00 |
| Depreciation | 356.00 | 298.00 | 19.46 | 1384.00 | 1152.00 | 20.14 | 1384.00 | 1152.00 | 20.14 |
| PBT | -671.00 | 734.00 | -191.42 | 1559.00 | 3922.00 | -60.25 | 1559.00 | 3922.00 | -60.25 |
| TAX | -58.00 | 162.00 | -135.80 | 168.00 | 827.00 | -79.69 | 168.00 | 827.00 | -79.69 |
| Deferred Tax | 14.00 | -81.00 | -117.28 | -157.00 | -106.00 | 48.11 | -157.00 | -106.00 | 48.11 |
| PAT | -613.00 | 572.00 | -207.17 | 1391.00 | 3095.00 | -55.06 | 1391.00 | 3095.00 | -55.06 |
| Equity | 365.00 | 365.00 | 0.00 | 365.00 | 365.00 | 0.00 | 365.00 | 365.00 | 0.00 |
| PBIDTM(%) | -5.31 | 33.87 | -115.68 | 17.40 | 31.37 | -44.53 | 17.40 | 31.37 | -44.53 |